Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial
Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page
- Check6 days agoChange DetectedAdded a government funding notice about site status and that the NIH Clinical Center is open; updated Revision: v3.4.1 and removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check13 days agoChange DetectedResults for SANCTUARY (NCT04564339) were posted on 2026-01-22, including Week 26 and Week 50 proteinuria and eGFR outcomes for LN and IgAN cohorts; several previously listed result metrics were removed.SummaryDifference3%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays 'Results Submitted' instead of 'No Results Posted' and the revision version updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check48 days agoChange DetectedLocations sections are consolidated under a single 'Locations' heading with updated states/countries; the HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.9%

- Check70 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing v3.3.1; this is a minor site maintenance update and does not alter study details or how to use the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedPublications in PubMed section now include an explicit note that entries are automatically filled and may not be directly related to the study; the revision tag updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.